Quick Answer
Decoy Therapeutics Inc. reported Stockholders Equity of $5.89 million for fiscal year 2025.
Decoy Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.89M | +289.6% |
| 2024 | $1.51M | -71.4% |
| 2023 | $5.29M | -49.1% |
| 2022 | $10.38M | -73.2% |
| 2021 | $38.72M | +74.7% |
| 2020 | $22.16M | +109.4% |
| 2019 | $10.58M | +932.4% |
| 2018 | -$1.27M | +56.2% |
| 2017 | -$2.90M | -104.9% |
| 2016 | $59.32M | -35.7% |
| 2015 | $92.19M | +1510.0% |
| 2014 | -$6.54M | — |
| 2014 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.25M | +45.3% | +612.0% |
| June 30, 2025 | -$829.7K | -134.9% | -1441.2% |
| March 31, 2025 | $61.9K | -98.3% | -95.9% |
| December 31, 2024 | $1.51M | -71.4% | -48.3% |
| September 30, 2024 | $2.92M | -51.9% | +23.1% |
| June 30, 2024 | $2.38M | -71.8% | -34.9% |
| March 31, 2024 | $3.65M | -34.3% | -31.0% |
| December 31, 2023 | $5.29M | -49.1% | -13.1% |
- Decoy Therapeutics Inc. showed an increase of +289.6% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Decoy Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: